0.00Open0.02Pre Close0 Volume409 Open Interest2.50Strike Price0.00Turnover3747.75%IV72.72%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-3DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0929Delta0.3114Gamma72.96Leverage Ratio-1.1511Theta0.0000Rho6.78Eff Leverage0.0000Vega
Immunic Stock Discussion
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...
PR Newswire· 1 min ago
get the lead out 😜
No comment yet